Shopping Cart 0
Cart Subtotal
USD 0

Sichuan Kelun Pharmaceutical Co Ltd (002422) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Sichuan Kelun Pharmaceutical Co., Ltd. (Kelun) is engaged in manufacturing and distribution of IV Solutions. The company's products portfolio includes glucose injection, sodium chloride injection, glucose and sodium chloride injection, ringer's injection, lactated ringer's injection, compound amino acid injection, alanyl glutamine injection, compound amino acids, fat emulsion injection, vitamin c and glucose injection, vitamin c and sodium chloride injection, among others. It also offers products to serve parenteral nutrition, digestive system, cardiovascular, antipsychotic, respiratory system, anti-pathogenic microorganisms, and APIs and intermediates. The company is also involved in research and development of pharmaceutical products. Kelun is headquartered in Chengdu, Sichuan, China.

Sichuan Kelun Pharmaceutical Co Ltd (002422)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Sichuan Kelun Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 12

Debt Offering 12

Sichuan Kelun Pharma to Raise USD63.3 Million in Private Placement of Bonds Due 2018 12

Sichuan Kelun Pharma Raises USD111.2 Million in Public Offering of 5.65% 2018 Second Tranche Notes 13

Sichuan Kelun Pharma Raises USD79 Million in Public Offering of 6.2% 2018 First Tranche Notes Due 2021 14

Sichuan Kelun Pharma Raises USD210 Million in First Tranche of Public Offering of 5.38% Notes Due 2020 15

Sichuan Kelun Pharma Raises USD206.9 Million in Second Tranche of Public Offering 16

Sichuan Kelun Pharma Raises USD88.6 Million in Public Offering of 5.38% Bonds Due 2020 17

Sichuan Kelun Pharma Raises USD58 Million in Public Offering of 4.89% Bonds Due 2022 18

Sichuan Kelun Pharma Raises USD72.7 Million in Public Offering of Bonds 19

Sichuan Kelun Pharma Completes Public Offering Of Bonds Due 2018 For USD 175 Million 20

Sichuan Kelun Pharma Completes Public Offering Of Bonds Due 2017 For USD 238 Million 21

Sichuan Kelun Pharma Announces Debt Offering Of Notes Due 2017 For USD 412 Million 22

Acquisition 23

Sichuan Kelun Pharma to Acquire Xinjiang-Based Biomedicine company for USD3 Million 23

Sichuan Kelun Pharma Plans to Acquire 35% stake in Changshu-Based Biotechnology Company 24

Sichuan Kelun Pharma Plans to Acquire Remaining 20% stake in Guangxi-Based Pharmaceutical Unit for USD5.3 Million 25

Sichuan Kelun Pharma Acquires KLUS Pharma for USD13 Million 26

Sichuan Kelun Pharma to Acquire 80% Stake in Biotechnology Company 27

Sichuan Kelun Pharma Plans to Acquire Remaining 15% Stake in Zhejiang-based pharmaceutical unit 28

Sichuan Kelun Pharma Acquires Guizhou Kelun Pharma, Pharmaceutical Preparations Manufacturer 29

Sichuan Kelun Pharma Acquires 56% Stake In Chengdu Pharma Company For USD 32.8 Million 30

Sichuan Kelun Pharmaceutical Co Ltd-Key Competitors 31

Sichuan Kelun Pharmaceutical Co Ltd-Key Employees 32

Sichuan Kelun Pharmaceutical Co Ltd-Locations And Subsidiaries 33

Head Office 33

Other Locations & Subsidiaries 33

Affiliate 34

Appendix 35

Methodology 35

About GlobalData 35

Contact Us 35

Disclaimer 35


List Of Figure

List of Figures

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Sichuan Kelun Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Sichuan Kelun Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8

Sichuan Kelun Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Sichuan Kelun Pharma to Raise USD63.3 Million in Private Placement of Bonds Due 2018 12

Sichuan Kelun Pharma Raises USD111.2 Million in Public Offering of 5.65% 2018 Second Tranche Notes 13

Sichuan Kelun Pharma Raises USD79 Million in Public Offering of 6.2% 2018 First Tranche Notes Due 2021 14

Sichuan Kelun Pharma Raises USD210 Million in First Tranche of Public Offering of 5.38% Notes Due 2020 15

Sichuan Kelun Pharma Raises USD206.9 Million in Second Tranche of Public Offering 16

Sichuan Kelun Pharma Raises USD88.6 Million in Public Offering of 5.38% Bonds Due 2020 17

Sichuan Kelun Pharma Raises USD58 Million in Public Offering of 4.89% Bonds Due 2022 18

Sichuan Kelun Pharma Raises USD72.7 Million in Public Offering of Bonds 19

Sichuan Kelun Pharma Completes Public Offering Of Bonds Due 2018 For USD 175 Million 20

Sichuan Kelun Pharma Completes Public Offering Of Bonds Due 2017 For USD 238 Million 21

Sichuan Kelun Pharma Announces Debt Offering Of Notes Due 2017 For USD 412 Million 22

Sichuan Kelun Pharma to Acquire Xinjiang-Based Biomedicine company for USD3 Million 23

Sichuan Kelun Pharma Plans to Acquire 35% stake in Changshu-Based Biotechnology Company 24

Sichuan Kelun Pharma Plans to Acquire Remaining 20% stake in Guangxi-Based Pharmaceutical Unit for USD5.3 Million 25

Sichuan Kelun Pharma Acquires KLUS Pharma for USD13 Million 26

Sichuan Kelun Pharma to Acquire 80% Stake in Biotechnology Company 27

Sichuan Kelun Pharma Plans to Acquire Remaining 15% Stake in Zhejiang-based pharmaceutical unit 28

Sichuan Kelun Pharma Acquires Guizhou Kelun Pharma, Pharmaceutical Preparations Manufacturer 29

Sichuan Kelun Pharma Acquires 56% Stake In Chengdu Pharma Company For USD 32.8 Million 30

Sichuan Kelun Pharmaceutical Co Ltd, Key Competitors 31

Sichuan Kelun Pharmaceutical Co Ltd, Key Employees 32

Sichuan Kelun Pharmaceutical Co Ltd, Subsidiaries 33

Sichuan Kelun Pharmaceutical Co Ltd, Affiliate 34

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Sichuan Kelun Pharmaceutical Co Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.